Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials

Published:2016-01 Issue:1 Volume:3 Page:e000105
ISSN:2052-4439
Container-title:BMJ Open Respiratory Research
language:en
Short-container-title:BMJ Open Resp Res

Author:

Lancaster Lisa,Albera Carlo,Bradford Williamson Z,Costabel Ulrich,du Bois Roland M,Fagan Elizabeth A,Fishman Robert S,Glaspole Ian,Glassberg Marilyn K,King Talmadge E,Lederer David J,Lin Zhengning,Nathan Steven D,Pereira Carlos A,Swigris Jeffrey J,Valeyre Dominique,Noble Paul W

Publisher

BMJ

Subject

Pulmonary and Respiratory Medicine

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early pirfenidone treatment enhances lung function in idiopathic pulmonary fibrosis patients;World Journal of Clinical Cases;2024-10-06

2. Development of a Lipid-encapsulated TGFβRI-siRNA Drug for Liver Fibrosis Induced by Schistosoma mansoni;PLOS Neglected Tropical Diseases;2024-09-12

3. Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF);Expert Review of Clinical Pharmacology;2024-08-27

4. Safety, effectiveness, and usefulness of higher-dose tablets of generic pirfenidone in patients with IPF: a nationwide observational study in South Korea;Frontiers in Pharmacology;2024-08-09

5. Interstitial lung disease: a review of classification, etiology, epidemiology, clinical diagnosis, pharmacological and non-pharmacological treatment;Frontiers in Medicine;2024-04-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP